Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07061652 · ClinicalTrials.gov registry record · NA

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

A NA study of Cancer and Diabetes, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
162
Enrollment target
3
Study locations

NCT07061652: Recruiting NA study of Cancer and Diabetes, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT07061652 is a NA study of Cancer and Diabetes that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 162 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07061652, a NA study of Cancer and Diabetes, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
162 participants
Enrollment target
3
Study locations

Study Summary

This study investigates the feasibility, acceptability, and preliminary efficacy of enCompass Humana, a social support intervention for caregivers of patients with cancer and diabetes. The enCompass program aims to improve support for these caregivers through a randomized feasibility study of a pilot-tested coaching and navigation program. Caregiver services and system-level support are essential, but successful interventions for cancer caregivers are rarely standardized or systematically disseminated. Consequently, many programs do not reach the most underserved caregivers. Challenges to implementation include substantial clinical staff involvement, lack of dissemination and implementation information, and failure to tailor interventions to rural contexts. Despite the lack of standardized supportive interventions, national reports and legislative efforts increasingly recognize the need to support caregivers. Caregivers reported unmet needs in all domains of social support, including instrumental help (e.g., in-home help, housekeeping), logistical and coordination support (e.g., food delivery, accompanying patients to appointments), information about illness and progression, emotional support, self-care guidance, and financial assistance (e.g., parking costs, lost wages). Caregivers show high interest in services but cited uncertainty and lack of strategies for accessing resources. Many are unaware of existing services. Interviews with oncology clinicians and healthcare administrators revealed similar findings: resources exist, but there is no system to match them with caregivers' needs. Preliminary data suggest the intervention improves caregiver coping self-efficacy and reduces anxiety and depression in patients. With input from stakeholders, including caregivers, patients, family caregiving experts, and clinical care experts, the study team adapted the CARING application into enCompass to mitigate structural barriers and normalize support-seeking. The long-ter

Conditions Studied

Interventions

  • BEHAVIORAL Survey
  • OTHER the resource booklet from the American Cancer Society

Study Locations (3)

Florida

  • Moffitt Cancer Center - Tampa

North Carolina

  • UNC Lineberger Comprehensive Cancer Center - Chapel Hill

Vermont

  • University of Vermont Cancer Center - Burlington

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2025-07-03
Est. Completion 2026-06
Phase NA

What the Registry Record Tells You About NCT07061652

The ClinicalTrials.gov registry entry for NCT07061652 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Survey is the first listed.

NCT07061652 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, North Carolina, Vermont.

Frequently Asked Questions

What is clinical trial NCT07061652 about?

NCT07061652 is a clinical study titled "Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes". This study investigates the feasibility, acceptability, and preliminary efficacy of enCompass Humana, a social support intervention for caregivers of patients with cancer and diabetes. The enCompass program aims to improve support for these caregivers through a randomized feasibility study of a pilo...

What is the current status of trial NCT07061652?

This trial is currently recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2025-07-03. Estimated completion is 2026-06.

What conditions does trial NCT07061652 study?

This clinical trial studies the following conditions: Cancer, Diabetes.

What interventions are being tested in trial NCT07061652?

The interventions under investigation include: Survey (BEHAVIORAL), the resource booklet from the American Cancer Society (OTHER).

Who is sponsoring clinical trial NCT07061652?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07061652 being conducted?

This trial has 3 study locations across Florida, North Carolina, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.